Eric W. Wilkinson
Strategic Growth Advisor
Eric Wilkinson is a biotechnology executive, scientist and entrepreneur with more than 40 years of experience spanning executive leadership, research and development, intellectual property, technology commercialization, strategic partnering, licensing, business development, corporate finance and M&A. Throughout his career, he has helped develop and commercialize numerous technologies and products while building and leading biotechnology companies across domestic and international markets.
Eric has founded or co-founded more than 10 biotechnology startups and has served as President or Chief Executive Officer of six companies with direct P&L responsibility. He has also served on the boards of both public and private companies, bringing extensive experience in translating emerging technologies into scalable businesses and navigating organizations through development, commercialization, financing and growth.
Over the past decade, Eric has focused extensively on the development and growth of biotechnology and medical technology companies throughout Southeast Asia. He currently serves as Entrepreneur in Residence at Duke-NUS Medical School in Singapore and holds advisory roles with GreyRigge Associates in Japan and Katan Associates in the United States.
Professional Experience
- Duke-NUS Medical School, Entrepreneur in Residence
- Katan Associates, Associate
- GreyRigge Associates, Associate
- XL TechGroup, Vice President
- DxTech, Managing Director
Areas of Expertise
- Biotechnology & MedTech Strategy
- Company Formation & Commercialization
- Strategic Partnerships & Licensing
- Business Development & International Growth
- Corporate Finance & M&A